Stock Offering
What Is Dilution in Biotech? How Capital Raises Affect Shareholders
Dilution is one of the most frequently recurring events in the world of clinical-stage biotech investing, and one of the most misunderstood by retail investors encountering it for the first time. When a biotech company raises capital by issuing new shares, the total share count increases — which means each existing shareholder now owns a…
